GlobeNewswire - Health http://www.yebxqs.cn/RssFeed/subjectcode/20-Health/feedTitle/GlobeNewswire%20-%20Health Contains the last 20 releases newsdesk@globenewswire.com (NewsDesk) Wed, 24 Feb 2021 16:15:58 GMT webmaster@globenewswire.com (Webmaster) http://www.yebxqs.cn/news-release/2021/02/24/2181685/0/en/5th-International-Health-and-Wellness-Tourism-Congress-to-be-Held-June-9th-and-10th-in-Dominican-Republic.html http://www.yebxqs.cn/news-release/2021/02/24/2181685/0/en/5th-International-Health-and-Wellness-Tourism-Congress-to-be-Held-June-9th-and-10th-in-Dominican-Republic.html 5th International Health and Wellness Tourism Congress to be Held June 9th and 10th in Dominican Republic The Dominican Health Tourism Association and AF Comunicación Estratégica Host Summit for Health and Wellness Tourism Professionals]]> Wed, 24 Feb 2021 16:15 GMT 2181685 en GlobeNewswire Inc. AF Comunicación Estratégica Wed, 24 Feb 2021 16:16 GMT Dr. Alejandro Cambiaso - President of the Dominican Health Tourism Association y Amelia Reyes Mora - President of AF Comunicacio?n Estrate?gica


]]>
GlobeNewswire Inc.
Health Travel Press releases Other News AF Comunicacion Estrategica Health Tourism Health Tourism Conference
http://www.yebxqs.cn/news-release/2021/02/24/2181671/0/en/NorthStar-Moving-Partners-with-LC-Pool-Design-Consultation.html http://www.yebxqs.cn/news-release/2021/02/24/2181671/0/en/NorthStar-Moving-Partners-with-LC-Pool-Design-Consultation.html NorthStar Moving Partners with LC Pool Design + Consultation Pool consulting firm provides design advice to create safe & sophisticated pools]]> Wed, 24 Feb 2021 16:07 GMT 2181671 en GlobeNewswire Inc. NorthStar Moving Company Wed, 24 Feb 2021 16:08 GMT Health Lifestyle Partnerships Product / Services Announcement NorthStar Moving Company LC Pool Design safety home design pools backyard landscaping moving family pools pool safety pool sales http://www.yebxqs.cn/news-release/2021/02/24/2181655/0/en/Study-Finds-Low-Rate-of-COVID-19-Among-Dental-Hygienists.html http://www.yebxqs.cn/news-release/2021/02/24/2181655/0/en/Study-Finds-Low-Rate-of-COVID-19-Among-Dental-Hygienists.html Study Finds Low Rate of COVID-19 Among Dental Hygienists Joint research investigates pandemic’s impact on infection control practices in dental health setting; employment rate of dental hygienists]]> Wed, 24 Feb 2021 16:00 GMT 2181655 en GlobeNewswire Inc. American Dental Association Wed, 24 Feb 2021 16:00 GMT Health http://www.yebxqs.cn/news-release/2021/02/24/2181635/0/zh-hans/Cybrexa-Therapeutics%E4%B8%8E%E7%BE%8E%E5%9B%BD%E5%9B%BD%E5%AE%B6%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%E6%89%80%E7%AD%BE%E8%AE%A2%E5%90%88%E4%BD%9C%E7%A0%94%E5%8F%91%E5%8D%8F%E8%AE%AE-CRADA-%E4%BB%A5%E5%BC%80%E5%8F%91CBX-12-alphalex-exatecan.html http://www.yebxqs.cn/news-release/2021/02/24/2181635/0/zh-hans/Cybrexa-Therapeutics%E4%B8%8E%E7%BE%8E%E5%9B%BD%E5%9B%BD%E5%AE%B6%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%E6%89%80%E7%AD%BE%E8%AE%A2%E5%90%88%E4%BD%9C%E7%A0%94%E5%8F%91%E5%8D%8F%E8%AE%AE-CRADA-%E4%BB%A5%E5%BC%80%E5%8F%91CBX-12-alphalex-exatecan.html Cybrexa Therapeutics与美国国家癌症研究所签订合作研发协议(CRADA)以开发CBX-12(alphalex?- exatecan) - Cybrexa与NCI将合作开发Cybrexa的主要候选药物CBX-12,以评估对实体肿瘤患者的安全性和疗效 -

]]>
Wed, 24 Feb 2021 15:38 GMT 2181635 zh-Hans GlobeNewswire Inc. Cybrexa Therapeutics Wed, 24 Feb 2021 15:38 GMT Health
http://www.yebxqs.cn/news-release/2021/02/24/2181587/0/en/Pan-Biome-Pharmaceuticals-Inc-reports-positive-results-in-preclinical-trial-of-Inflammatory-Bowel-Disease-oral-drug-shows-strong-effect-in-modulating-the-gut-microbiome.html http://www.yebxqs.cn/news-release/2021/02/24/2181587/0/en/Pan-Biome-Pharmaceuticals-Inc-reports-positive-results-in-preclinical-trial-of-Inflammatory-Bowel-Disease-oral-drug-shows-strong-effect-in-modulating-the-gut-microbiome.html Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical?company focused on?chronic inflammatory?and autoimmune diseases,?is pleased to announce that?one of its drugs?produced?strong effects?in modulating gut microbiota?in a mouse model study of?inflammatory bowel disease.?In a study run by the?Gut4Health Microbiome Core?at?BC’s Children’s Hospital Research Institute,?the?compound?induced?a?distinct?shift in?microbiota composition, by increasing?“good” bacteria?while?suppressing?bacteria?associated with?the development?of?obesity?and?type 2?diabetes.?Particularly exciting was the finding that our compound induced a substantial increase in the species Akkermansia?muciniphila, a bacterium?shown to elicit?a wide range of?positive health benefits,?including reduced?obesity and systemic inflammation, and improved?gut barrier function.?Chronic?diseases driven by?obesity and?obesity-related?conditions?accounted for?over?$480 billion?USD?in direct health care costs?in the U.S.?alone?(2016).?

]]>
Wed, 24 Feb 2021 15:00 GMT 2181587 en GlobeNewswire Inc. Pan-Biome Pharmaceuticals, Inc Wed, 24 Feb 2021 15:00 GMT Health autoimmune microbiome gut antioxidant microbiota modulation akkermansia disease probiotics diabetes obesity IBD chronic inflammation
http://www.yebxqs.cn/news-release/2021/02/24/2181543/0/en/AIM-ImmunoTech-s-Subsidiary-Receives-Orphan-Medicinal-Product-Designation-by-the-European-Medicines-Agency-for-Ampligen-to-Treat-Pancreatic-Cancer.html http://www.yebxqs.cn/news-release/2021/02/24/2181543/0/en/AIM-ImmunoTech-s-Subsidiary-Receives-Orphan-Medicinal-Product-Designation-by-the-European-Medicines-Agency-for-Ampligen-to-Treat-Pancreatic-Cancer.html NYSE:AIM US00901B1052 AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer OCALA, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that its subsidiary, NV Hemispherx Biopharma Europe, has received formal notification from the European Commission (EC) approving the company’s Orphan Medicinal Product Application for Ampligen as a treatment for pancreatic cancer.

]]>
Wed, 24 Feb 2021 14:15 GMT 2181543 en GlobeNewswire Inc. AIM ImmunoTech Inc. Wed, 24 Feb 2021 14:15 GMT Prof. Casper van Eijck, surgeon and a global leading expert in pancreatic cancer


]]>
GlobeNewswire Inc.
Kazem Kazempour, Ph.D., CEO and President of Amarex Clinical Research, LLC


]]>
GlobeNewswire Inc.
Health Product / Services Announcement pancreatic cancer
http://www.yebxqs.cn/news-release/2021/02/24/2181504/0/en/Locus-Biosciences-completes-first-of-its-kind-controlled-clinical-trial-for-CRISPR-enhanced-bacteriophage-therapy.html http://www.yebxqs.cn/news-release/2021/02/24/2181504/0/en/Locus-Biosciences-completes-first-of-its-kind-controlled-clinical-trial-for-CRISPR-enhanced-bacteriophage-therapy.html Locus Biosciences completes first-of-its-kind controlled clinical trial for CRISPR-enhanced bacteriophage therapy Phase 1b trial demonstrates that the company’s lead precision medicine asset is safe and well tolerated]]> Wed, 24 Feb 2021 14:00 GMT 2181504 en GlobeNewswire Inc. Locus Biosciences Wed, 24 Feb 2021 14:00 GMT Health Product / Services Announcement locus biosciences http://www.yebxqs.cn/news-release/2021/02/24/2181489/0/en/New-Program-Urges-Consumers-and-Medical-Professionals-to-Trade-Up-Their-Non-Contact-Thermometers-Toward-an-Accurate-Temporal-Artery-Thermometer.html http://www.yebxqs.cn/news-release/2021/02/24/2181489/0/en/New-Program-Urges-Consumers-and-Medical-Professionals-to-Trade-Up-Their-Non-Contact-Thermometers-Toward-an-Accurate-Temporal-Artery-Thermometer.html New Program Urges Consumers and Medical Professionals to Trade Up Their Non-Contact Thermometers Toward an Accurate Temporal Artery Thermometer WATERTOWN, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- With non-contact thermometers still used widely for public screenings and in homes, extensive evidence of their inaccuracies in detecting fever puts many people at risk of unknowingly transmitting COVID or delaying treatments.

]]>
Wed, 24 Feb 2021 13:53 GMT 2181489 en GlobeNewswire Inc. Exergen Corporation Wed, 24 Feb 2021 13:53 GMT Company Announcement Health health medical
http://www.yebxqs.cn/news-release/2021/02/24/2181482/0/en/Laboratory-Automation-Systems-Market-to-Reach-USD-6-39-Billion-by-2028-Increase-in-Global-Research-and-Development-Activities-Rapid-Adoption-of-Laboratory-Automation-Systems-are-Ke.html http://www.yebxqs.cn/news-release/2021/02/24/2181482/0/en/Laboratory-Automation-Systems-Market-to-Reach-USD-6-39-Billion-by-2028-Increase-in-Global-Research-and-Development-Activities-Rapid-Adoption-of-Laboratory-Automation-Systems-are-Ke.html Laboratory Automation Systems Market to Reach USD 6.39 Billion by 2028 | Increase in Global Research and Development Activities & Rapid Adoption of Laboratory Automation Systems are Key Factors Driving Industry Growth, says Emergen Research Key players operating in the market are Tecan Group., PerkinElmer, Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, F. Hoffmann-La Roche, QIAGEN N.V., Siemens Healthineers, Eppendorf AG, bioMérieux, and Abbott.]]> Wed, 24 Feb 2021 13:45 GMT 2181482 en GlobeNewswire Inc. Emergen Research Wed, 24 Feb 2021 13:46 GMT Feature Article Health Market Research Reports Press releases Research Analysis and Reports Laboratory Automation Systems Laboratory automation market Lab automation market Lab automation systems market http://www.yebxqs.cn/news-release/2021/02/24/2181439/0/en/2021-Best-Places-to-Work-in-Indiana.html http://www.yebxqs.cn/news-release/2021/02/24/2181439/0/en/2021-Best-Places-to-Work-in-Indiana.html Nasdaq:KIDS US68752L1008 2021 Best Places to Work in Indiana WARSAW, Ind., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, today announced it was recently named as one of the 2021 Best Places to Work in Indiana. This is the 5th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce and Best Companies Group.??

]]>
Wed, 24 Feb 2021 13:30 GMT 2181439 en GlobeNewswire Inc. OrthoPediatrics Corp. Wed, 24 Feb 2021 13:30 GMT Company Announcement Health
http://www.yebxqs.cn/news-release/2021/02/24/2181448/0/en/TAAT-Lifestyle-Wellness-Ltd-CSE-TAAT-OTCQB-TOBAF-Carving-Out-New-Market-Niche.html http://www.yebxqs.cn/news-release/2021/02/24/2181448/0/en/TAAT-Lifestyle-Wellness-Ltd-CSE-TAAT-OTCQB-TOBAF-Carving-Out-New-Market-Niche.html CNSX:TAAT OTC Markets:TOBAF Frankfurt:2TP2 CA87320L1031 TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Carving Out New Market Niche NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via InvestorWireTAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

]]>
Wed, 24 Feb 2021 13:30 GMT 2181448 en GlobeNewswire Inc. TAAT Lifestyle & Wellness Ltd. Wed, 24 Feb 2021 13:30 GMT Feature Article Company Announcement Health Lifestyle Press releases tobacco alternative tobacco health addiction smoking nicotine tobacco-free nicotine-free cigarette stocks invest sales retail selling
http://www.yebxqs.cn/news-release/2021/02/24/2181455/0/en/Ayr-Wellness-Announces-Opening-of-Second-Dispensary-in-Pennsylvania.html http://www.yebxqs.cn/news-release/2021/02/24/2181455/0/en/Ayr-Wellness-Announces-Opening-of-Second-Dispensary-in-Pennsylvania.html CNSX:AYR.A CNSX:AYR.A.CN Other OTC:AYRWF CNSX:AYR-A.CN CNSX:AYR-A CA05475P1099 Ayr Wellness Announces Opening of Second Dispensary in Pennsylvania Ayr Wellness Plymouth Meeting Grand Opening Scheduled for February 26, 2021

]]>
Wed, 24 Feb 2021 13:30 GMT 2181455 en GlobeNewswire Inc. Ayr Wellness Inc. Wed, 24 Feb 2021 13:31 GMT Ayr Wellness Announces Opening of Second Dispensary in Pennsylvania


]]>
GlobeNewswire Inc.
Health Product / Services Announcement
http://www.yebxqs.cn/news-release/2021/02/24/2181466/0/en/Rhythm-Pharmaceuticals-to-Present-at-Cowen-Co-41st-Annual-Health-Care-Conference.html http://www.yebxqs.cn/news-release/2021/02/24/2181466/0/en/Rhythm-Pharmaceuticals-to-Present-at-Cowen-Co-41st-Annual-Health-Care-Conference.html Nasdaq:RYTM US76243J1051 Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference BOSTON, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M.D., President and Chief Executive Officer, will participate in a fireside chat at the Cowen & Co. 41st Annual Health Care Conference on Wednesday, March 3, 2021 at 2:40 p.m. ET.

]]>
Wed, 24 Feb 2021 13:30 GMT 2181466 en GlobeNewswire Inc. Rhythm Pharmaceuticals, Inc. Wed, 24 Feb 2021 13:32 GMT Calendar of Events Health
http://www.yebxqs.cn/news-release/2021/02/24/2181431/0/en/2021-2028-Breathalyzers-Market-Size-Share-Growth-Trends-Revenue-Competitive-Landscape-Forecast-Report.html http://www.yebxqs.cn/news-release/2021/02/24/2181431/0/en/2021-2028-Breathalyzers-Market-Size-Share-Growth-Trends-Revenue-Competitive-Landscape-Forecast-Report.html [2021-2028] Breathalyzers Market Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report Key Prominent Players Covered in the Breathalyzers Market Research Report Are AK Global Tech Corp., Intoximeters, BACtrack, Lifeloc Technologies Inc., Abbott, Quest Products, Inc., Hound Labs, Inc., Tobii Dynavox, PRC-Saltillo, Dr?gerwerk AG & Co. KGaA, Lingraphica, other key market players.]]> Wed, 24 Feb 2021 13:22 GMT 2181431 en GlobeNewswire Inc. Fortune Business Insights Wed, 24 Feb 2021 13:22 GMT Health Business Contracts Annual report Press releases Mergers and Acquisitions Breathalyzers Market Breathalyzers Market Size Breathalyzers Market Share Breathalyzers Market Growth Breathalyzers http://www.yebxqs.cn/news-release/2021/02/24/2181423/0/en/Urodynamic-Equipment-and-Consumables-Market-growing-at-6-5-CAGR-by-2027-The-Insight-Partners.html http://www.yebxqs.cn/news-release/2021/02/24/2181423/0/en/Urodynamic-Equipment-and-Consumables-Market-growing-at-6-5-CAGR-by-2027-The-Insight-Partners.html Urodynamic Equipment and Consumables Market growing at 6.5% CAGR by 2027 – The Insight Partners Increase in Incidence of Chronic Diseases Leading to Kidney Diseases is projected to Augment the Global Urodynamic Equipment And Consumables Market]]> Wed, 24 Feb 2021 13:16 GMT 2181423 en GlobeNewswire Inc. The Insight Partners Wed, 24 Feb 2021 13:17 GMT Health Research Analysis and Reports Market Research Reports Press releases Uroflowmetry Equipment Urodynamic Consumables Electromyographs Video Urodynamic Systems http://www.yebxqs.cn/news-release/2021/02/24/2181360/0/en/Oncternal-Therapeutics-to-Participate-in-March-Investor-Conferences.html http://www.yebxqs.cn/news-release/2021/02/24/2181360/0/en/Oncternal-Therapeutics-to-Participate-in-March-Investor-Conferences.html Nasdaq:ONCT US68236P1075 Oncternal Therapeutics to Participate in March Investor Conferences - H.C. Wainwright: Global Life Sciences Conference -
March 9th – 10th

]]>
Wed, 24 Feb 2021 13:00 GMT 2181360 en GlobeNewswire Inc. Oncternal Therapeutics Wed, 24 Feb 2021 13:02 GMT Calendar of Events Health
http://www.yebxqs.cn/news-release/2021/02/24/2181373/0/en/Motus-GI-Announces-U-S-Patent-for-the-Pure-Vu-System-s-Connectivity-with-Nearly-All-Commercial-Colonoscopes-to-Provide-Improved-Visualization-During-Colonoscopy.html http://www.yebxqs.cn/news-release/2021/02/24/2181373/0/en/Motus-GI-Announces-U-S-Patent-for-the-Pure-Vu-System-s-Connectivity-with-Nearly-All-Commercial-Colonoscopes-to-Provide-Improved-Visualization-During-Colonoscopy.html Nasdaq:MOTS US62014P1084 Motus GI Announces U.S. Patent for the Pure-Vu? System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy FORT LAUDERDALE, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, today announced that the U.S. Patent and Trademark Office (USPTO) has issued patent no. 10,925,466, which is titled, “Apparatus and method for coupling between a colonoscope and add-on tubes”.

]]>
Wed, 24 Feb 2021 13:00 GMT 2181373 en GlobeNewswire Inc. Motus GI Holdings, Inc. Wed, 24 Feb 2021 13:02 GMT Health Patents
http://www.yebxqs.cn/news-release/2021/02/24/2181379/0/en/Montreal-Chest-Institute-Foundation-and-MUHC-Foundation-join-forces-to-change-the-course-of-lives-and-medicine.html http://www.yebxqs.cn/news-release/2021/02/24/2181379/0/en/Montreal-Chest-Institute-Foundation-and-MUHC-Foundation-join-forces-to-change-the-course-of-lives-and-medicine.html Montreal Chest Institute Foundation and MUHC Foundation join forces to change the course of lives and medicine A merger and the launch of a $10 million dollar respiratory campaign, part of the McGill University Health Centre Foundation’s larger Dream Big campaign, will ensure the Montreal Chest Institute will continue as a world leader in respiratory care]]> Wed, 24 Feb 2021 13:00 GMT 2181379 en GlobeNewswire Inc. MUHC Foundation Wed, 24 Feb 2021 13:03 GMT Chest


]]>
GlobeNewswire Inc.
Partnerships Health
http://www.yebxqs.cn/news-release/2021/02/24/2181379/0/fr/La-Fondation-de-l-Institut-thoracique-de-Montr%C3%A9al-et-la-Fondation-du-CUSM-unissent-leurs-forces-pour-transformer-des-vies-et-faire-%C3%A9voluer-la-m%C3%A9decine.html http://www.yebxqs.cn/news-release/2021/02/24/2181379/0/fr/La-Fondation-de-l-Institut-thoracique-de-Montr%C3%A9al-et-la-Fondation-du-CUSM-unissent-leurs-forces-pour-transformer-des-vies-et-faire-%C3%A9voluer-la-m%C3%A9decine.html La Fondation de l’Institut thoracique de Montréal et la Fondation du CUSM unissent leurs forces pour transformer des vies et faire évoluer la médecine Cette fusion et le lancement d’une campagne de 10?millions de dollars pour la santé respiratoire, dans le cadre de la vaste campagne Osez rêver de la Fondation du Centre universitaire de santé McGill, permettront à l’Institut thoracique de Montréal de demeurer un chef de file mondial dans le domaine des soins respiratoires]]> Wed, 24 Feb 2021 13:00 GMT 2181379 fr GlobeNewswire Inc. MUHC Foundation Wed, 24 Feb 2021 13:03 GMT Transformer des vies et faire évoluer la médecine.


]]>
GlobeNewswire Inc.
Partnerships Health
http://www.yebxqs.cn/news-release/2021/02/24/2181393/0/en/Cyprium-Therapeutics-a-Fortress-Biotech-Partner-Company-and-Sentynl-Therapeutics-a-Wholly-owned-Subsidiary-of-the-Zydus-Group-Sign-Development-and-Asset-Purchase-Agreement-for-Cypr.html http://www.yebxqs.cn/news-release/2021/02/24/2181393/0/en/Cyprium-Therapeutics-a-Fortress-Biotech-Partner-Company-and-Sentynl-Therapeutics-a-Wholly-owned-Subsidiary-of-the-Zydus-Group-Sign-Development-and-Asset-Purchase-Agreement-for-Cypr.html Nasdaq:FBIO US34960Q1094 Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of the Zydus Group, Sign Development and Asset Purchase Agreement for Cyprium Therapeutics’ Copper Histidinate Product Candidate for Treatment of Menkes Disease Sentynl acquires CUTX-101, Copper Histidinate, for $20 million in upfront and regulatory milestone payments through NDA approval, as well as potential sales milestones plus royalties

]]>
Wed, 24 Feb 2021 13:00 GMT 2181393 en GlobeNewswire Inc. Fortress Biotech, Inc. Wed, 24 Feb 2021 13:03 GMT Business Contracts Health
粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号